Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.

about

Future Perspectives on Endoscopic Ultrasonography-Guided Therapy for Pancreatic Neoplasm.

P2860

Q55382636-D379D727-6ADD-4AA2-9B04-C89CADA4FFD8

P2860

Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.

Item

http://www.wikidata.org/entity/Q52963237

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@en

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@nl

type

Item

label

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@en

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@nl

prefLabel

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@en

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@nl

P1476

Pancreatic Duct Involvement in ...... endent Poor Prognostic Factor.

@en

P2093

Hirochika Toyama

http://www.w3.org/2001/XMLSchema#string

Ippei Matsumoto

http://www.w3.org/2001/XMLSchema#string

Jun Uemura

http://www.w3.org/2001/XMLSchema#string

Keiichi Okano

http://www.w3.org/2001/XMLSchema#string

Kyoko Otani

http://www.w3.org/2001/XMLSchema#string

Sadaki Asari

http://www.w3.org/2001/XMLSchema#string

Tadahiro Goto

http://www.w3.org/2001/XMLSchema#string

Takumi Fukumoto

http://www.w3.org/2001/XMLSchema#string

Tetsuo Ajiki

http://www.w3.org/2001/XMLSchema#string

Yasuyuki Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

Malignant islet cell tumor projecting into the main pancreatic duct.

Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Lymph nodes and survival in pancreatic neuroendocrine tumors.

Endocrine tumours of the pancreas.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.

Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.

Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors.

Small serotonin-positive pancreatic endocrine tumors caused obstruction of the main pancreatic duct.

P2888

s10434-016-5663-8

P304

1127-1133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-016-5663-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048377282

http://www.w3.org/2001/XMLSchema#string

P698

27822631

http://www.w3.org/2001/XMLSchema#string

Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.

about

P2860

P2860

Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698